Investor Presentaiton

1. Q2 2023 Financial Review Total Revenue ($ millions) Operating Income ($ millions) Net Income ($ millions) 169.4 30.2 -7.1% 157.4 -25.1% 22.6 Q2 2022 Q2 2023 Q2 2022 21.0 -25.1% 15.7 Q2 2023 Q2 2022 Q2 2023 //Andlauer HEALTHCARE GROUP EBITDA ($millions) and Margin (%) 1 46.3 -14.7% 39.5 27.3% 25.1% Q2 2022 Q2 2023 Q2 2022 EPS: $0.49 / share (diluted) Q2 2023 EPS: $0.37 / share (diluted) EBITDA is defined as net income (loss) and comprehensive income (loss) for the period before: (i) income tax (recovery) expense; (ii) interest income; (iii) interest expense; and (iv) depreciation and amortization 17

View entire presentation